NCT05567393View on ClinicalTrials.gov

A Study of TAK-951 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

November 2, 2020

Study Completion Date

November 2, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-951 Placebo

TAK-951 placebo-matching SC injection

DRUG

TAK-951

TAK-951 SC injection

Trial Locations (1)

91206

California Clinical Trials Medical Group, Glendale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY